Patents by Inventor Danielle Gline Allen

Danielle Gline Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156510
    Abstract: A system for modulating delivery of radiofrequency (RF) power to tissue, the system including an RF applicator configured for being positioned adjacent to tissue, an RF generator electrically coupled to the RF applicator, and a controller operatively coupled to the RF generator. The controller includes a tissue impedance measurement circuit operatively coupled with the RF applicator and configured for measuring an impedance of tissue disposed adjacent to the RF applicator, and a power modulation module configured to cause RF power to be delivered from the RF generator to the tissue disposed adjacent to the RF applicator so that an impedance of the tissue tracks a target tissue impedance as a function of time.
    Type: Application
    Filed: January 18, 2024
    Publication date: May 16, 2024
    Applicant: HOLOGIC, INC.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Patent number: 11918276
    Abstract: A system is configured to delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, including modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve that is determined based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Grant
    Filed: January 5, 2023
    Date of Patent: March 5, 2024
    Assignee: Hologic, Inc.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Publication number: 20230157742
    Abstract: A system is configured to delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, including modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve that is determined based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Application
    Filed: January 5, 2023
    Publication date: May 25, 2023
    Applicant: HOLOGIC, INC.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Patent number: 11559348
    Abstract: A system is configured to delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, including modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve that is determined based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: January 24, 2023
    Assignee: Hologic, Inc.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Publication number: 20200375650
    Abstract: A system is configured to delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, including modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve that is determined based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Application
    Filed: August 20, 2020
    Publication date: December 3, 2020
    Applicant: HOLOGIC, INC.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Patent number: 10779877
    Abstract: A system is configured to delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, including modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve that is determined based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: September 22, 2020
    Assignee: Hologic, Inc.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Publication number: 20180280072
    Abstract: A system is configured to delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, including modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve that is determined based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Application
    Filed: June 6, 2018
    Publication date: October 4, 2018
    Applicant: HOLOGIC, INC.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Patent number: 10004553
    Abstract: A method of ablating endometrial lining tissue, includes delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, and modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time, wherein the target tissue impedance is derived from a function that approximates a preferred endometrial lining tissue ablation impedance curve, scaled based upon a measured impedance of the endometrial lining tissue after RF power has been delivered for a predetermined initial time period.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: June 26, 2018
    Assignee: Hologic, Inc.
    Inventors: William Lucas Churchill, Danielle Gline Allen
  • Publication number: 20150173826
    Abstract: A method of ablating endometrial lining tissue, includes delivering radiofrequency power to the endometrial lining tissue of a uterine cavity, and modulating the delivered power so that a measured impedance of the endometrial lining tissue tracks a target impedance as a function of time.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 25, 2015
    Inventors: William Lucas Churchill, Danielle Gline Allen